skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: First, congrats on passing the 100,000 question mark. This is a remarkable achievement. Well done.
Can subscribers expect a special dividend payment?
Reading Knight Therapeutics' results and conference call recap, I learned Knight now has 700 employees, will have over $400M in cash after paying out all shareholders to conclude the purchase, concluded the battle with Medison, started expanding into Mexico on day one in December and does not foresee any financial stress on the company due to the virus. This is very positive. On the negative side, they obviously have a problem getting to Doctors although the flow of medicine is uninterrupted, two drugs were not designated for public funding by Health Canada and, obviously, the timing of the purchase would have most likely been better if done a couple of months later after the virus hit.
A couple of questions: would Knight have any options with the drugs refused public insurance or are they stuck with these investments and how much will that affect their business; do you think Knight will be able to use their vast international network to bring new drugs to Biotoscan that they may not have had access to; how much will the virus interfere with revenues in Canada, Israel and LatAm or will shipments continue as usual; and, finally, in general, do you think Knight, all situations considered, is on a positive trajectory for the future when the current crisis ends?
Thank you very much.
Read Answer Asked by Steven on April 02, 2020
Q: For those of us who still have Covalon shares, should we hold on to see if their product does have some promise? Or should we sell into strength. At one point, back pre-Saudi problems, you seemed to be very positive on the company: I had assumed you had a feeling for management and financial strength. Now, reading between the lines, you seem to be implying it is somewhat akin to a VSE mining stock promotion. (Maybe that's not a fair statement.) When I look at the product Covalon originally had regarding anti-infection of wounds, it makes some sense that they could pivot to something that might kill a virus. I understand that it would include sufficient alcohol to do the job, so is comparable to Purell. But they claim to have made something that would last longer than a simple alcohol wipe. I hear you say it is interesting, but I'm not quite sure how to take the fact that they were asked to re-write a somewhat promotional news release. Should we sell and then return when the product is more developed, or just hold for now?
Read Answer Asked by Gordon on April 01, 2020
Q: Hello 5i Team
Are there any restrictions to the percentage of foreign equity within a RRSP? From everything I have seen so far with the merger of TSGI The Stars Group and Flutter will be OK in terms of if I can hold a UK stock in our SpousalRRSP but will it matter that it is over 10% of that account (not of all combined accounts)? I really do not want to sell it as it has not performed and I still have faith in it.
Thank you
Jeremy
Read Answer Asked by Jeremy on March 31, 2020
Q: Good morning 5i
And thanks for the continuing good advice in this difficult time. I know that you lack confidence in Toy's management following their errors during the best selling season and their failure in estimating future revenu. But, i have, now a small position, in a non registered account. I am thinking about buying the same amount in a registered account and in a month selling in the non registered account. This will allow me to take the tax loss selling, without fear that the stock shoots up in that time. i take seriously your concern about toy. But, i imagine nothing catastrophic will happen in a month, would you agree?
Thanks
Read Answer Asked by joseph on March 30, 2020
Q: Hi folks, reading Q4/19 financials on Ag Growth...& 2020 outlook was mostly doom & gloom affecting their business, ie: US/China trade war & esp Covid-19. However, Afn/t received an amendment & extension of its credit facility with 5 Cdn banks with improved terms, and pushed out to 20 march 2025. Guess Q is...will AG Growth financially survive virus crisis..and for longer term..can U start to nibble on a position here. Recently took position in Ntr/t below $40 as will always be a market for food/agriculture...thanks as always. jb Piedmont QC
Read Answer Asked by John on March 30, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!